Published in Circulation on August 21, 2007
Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA. Am J Physiol Cell Physiol (2011) 1.56
Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation (2009) 1.55
Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res (2010) 1.39
Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res (2013) 1.27
The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res (2008) 1.23
Cell communications in the heart. Circulation (2010) 1.09
Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ Res (2012) 1.07
Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice. PLoS One (2014) 1.06
Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling. J Biol Chem (2010) 1.06
Mechanisms and management of doxorubicin cardiotoxicity. Herz (2011) 1.05
Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev (2011) 1.01
Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc (2014) 1.01
Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats. Cardiovasc Diabetol (2011) 0.98
Protein therapeutics for cardiac regeneration after myocardial infarction. J Cardiovasc Transl Res (2010) 0.97
Regulation of tissue morphogenesis by endothelial cell-derived signals. Trends Cell Biol (2014) 0.97
Neuregulin-1β for the treatment of systolic heart failure. J Mol Cell Cardiol (2011) 0.96
Affecting Rhomboid-3 function causes a dilated heart in adult Drosophila. PLoS Genet (2010) 0.93
Mouse models of gene-environment interactions in schizophrenia. Neurobiol Dis (2013) 0.90
Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia. Coron Artery Dis (2011) 0.88
Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies. Biochem Res Int (2012) 0.86
Drosophila models of cardiac disease. Prog Mol Biol Transl Sci (2011) 0.85
The effects of neuregulin on cardiac Myosin light chain kinase gene-ablated hearts. PLoS One (2013) 0.83
Vascular Toxicities of Cancer Therapies: The Old and the New - An Evolving Avenue. Circulation (2016) 0.82
Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity. Pharmacogenomics (2013) 0.82
Trastuzumab Induces an Immediate, Transient Volume Increase in Humans: A Randomised Placebo-Controlled Trial. EBioMedicine (2015) 0.82
Cardiovascular toxicities from systemic breast cancer therapy. Front Oncol (2014) 0.81
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents. Breast Cancer Res Treat (2013) 0.80
Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Biomaterials (2015) 0.80
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways. Curr Protoc Chem Biol (2015) 0.80
Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci (2014) 0.80
Associations of Sleep Apnea, NRG1 Polymorphisms, Alcohol Consumption, and Cerebral White Matter Hyperintensities: Analysis with Genome-Wide Association Data. Sleep (2015) 0.80
Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure. J Geriatr Cardiol (2012) 0.79
The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist (2013) 0.79
Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis (2015) 0.79
Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer. BMC Cancer (2016) 0.79
ErbB2 signaling at the crossing between heart failure and cancer. Basic Res Cardiol (2016) 0.79
Methylglyoxal-Induced Endothelial Cell Loss and Inflammation Contribute to the Development of Diabetic Cardiomyopathy. Diabetes (2016) 0.78
Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability. Biol Open (2016) 0.78
Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung. Oncotarget (2016) 0.78
Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study. J Cardiovasc Transl Res (2017) 0.78
Breast cancer therapy and cardiovascular risk: focus on trastuzumab. Vasc Health Risk Manag (2015) 0.77
Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers. J Am Heart Assoc (2016) 0.77
Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats. Exp Ther Med (2013) 0.77
And the beat goes on: maintained cardiovascular function during aging in the longest-lived rodent, the naked mole-rat. Am J Physiol Heart Circ Physiol (2014) 0.77
Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies? Hum Vaccin Immunother (2016) 0.76
Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk. Am J Physiol Endocrinol Metab (2016) 0.76
The Src homology and collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development. J Biol Chem (2014) 0.75
The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload. Sci Rep (2015) 0.75
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Cardiac actions of fibroblast growth factor 23. Bone (2016) 0.75
Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol (2017) 0.75
Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway. J Cell Mol Med (2017) 0.75
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation (2002) 2.65
Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem (2002) 1.79
Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res (2002) 1.65
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol (2005) 1.49
Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation (2004) 1.37
Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem (2006) 1.36
Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care (2013) 1.30
The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy. Circ Res (2010) 1.23
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Role of autophagy in heart failure associated with aging. Heart Fail Rev (2010) 1.06
Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am J Physiol Heart Circ Physiol (2002) 1.00
Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. Am J Physiol Heart Circ Physiol (2010) 0.99
The heart failure spectrum: time for a phenotype-oriented approach. Circulation (2009) 0.97
Molecular diversity of cardiac endothelial cells in vitro and in vivo. Physiol Genomics (2004) 0.91
Diastolic heart failure: a myth. Curr Opin Cardiol (2006) 0.91
Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Pflugers Arch (2007) 0.87
Pathophysiology of diastolic dysfunction in chronic heart failure. Future Cardiol (2013) 0.82
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol (2009) 0.82
Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug Discov Today (2013) 0.82
Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeutics. Int J Mol Sci (2012) 0.81
Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. J Mol Cell Cardiol (2008) 0.81
Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history. Curr Opin Cardiol (2012) 0.80
Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy. Eur J Heart Fail (2006) 0.78
Paving new paths for neuregulin-1-assisted cardiac regenerative medicine. Focus on "Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA". Am J Physiol Cell Physiol (2011) 0.78
Neuregulin-1 and its potential role in the control of cardiac function. Heart Fail Monit (2008) 0.77
Implementation of a quality improvement initiative in Belgian diabetic foot clinics: feasibility and initial results. Diabetes Metab Res Rev (2014) 0.77
Letter regarding article by Okoshi et al, "neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of {beta}-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion". Circulation (2005) 0.76
Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR). Acta Neurol Belg (2014) 0.75
Endocardial endothelium modulates subendocardial pH(i) of rabbit papillary muscles: role of transendothelial HCO(3)(-) transport. Cardiovasc Res (2004) 0.75
Inhibition of heme oxygenase-1 impairs cardiac muscle sensitivity to beta-adrenergic stimulation. Basic Res Cardiol (2005) 0.75
Effects of nebivolol on vascular endothelial and myocardial function in diabetes mellitus. J Cardiovasc Pharmacol (2011) 0.75